Clover Health Investments (CLOV) vs Veracyte (VCYT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Clover Health Investments (CLOV) has outperformed Veracyte (VCYT) over the past year, gaining 68.9% versus a gain of 24.7%. Over five years, VCYT leads with a -4.4% price change compared with -42.4% for CLOV. Veracyte is the larger company by market cap ($3.47 billion vs $2.42 billion), about 1.4 times the size.
On valuation, Veracyte trades at a lower forward P/E (22.1x vs 30.4x for Clover Health Investments).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLOV | VCYT |
|---|---|---|
| Share price | $4.56 | $43.16 |
| Market cap | $2.42B | $3.47B |
| 1-day change | -0.87% | -3.34% |
| YTD return | +94.04% | +2.52% |
| 1-year return | +68.89% | +24.70% |
| 5-year return | -42.35% | -4.43% |
| P/E ratio (TTM) | — | 31.97 |
| Forward P/E | 30.40 | 22.13 |
| EPS (TTM) | $-0.05 | $1.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.59 | $60.91 |
| 52-week low | $1.58 | $29.46 |
| Distance from 52-week high | -18.43% | -29.14% |
| Analyst consensus | none | buy |
| Avg. price target upside | +17.98% | +35.36% |
| Average volume | 4.27M | 1.35M |
| Shares outstanding | 435.44M | 80.39M |
| Employees | 724 | 755 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CLOV has outperformed VCYT by 44.2 percentage points over the past year.
About Clover Health Investments
CLOV stock →Clover Health Investments, Corp. provides medicare advantage plans in the United States.
Health Care · Medical Specialities · 724 employees
About Veracyte
VCYT stock →Veracyte, Inc. operates as a diagnostics company in the United States and internationally.
Health Care · Medical Specialities · 755 employees
CLOV vs VCYT FAQ
Which is bigger, Clover Health Investments or Veracyte?
Veracyte (VCYT) is larger, with a market capitalization of $3.47B compared with $2.42B for Clover Health Investments (CLOV).
Which stock has performed better over the past year, CLOV or VCYT?
CLOV returned +68.89% over the past 12 months, compared with +24.70% for VCYT (price return, excluding dividends). Past performance does not predict future results.
Are Clover Health Investments and Veracyte in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.